Background: Pancreatic cancer is the fourth most common cause of cancer related deaths in the world. Surgical resection remains the only potentially curative treatment for adenocarcinoma of the pancreas; only 10% - 20% of patients are candidate for standard pancreatic resection.
Objective: To evaluate perioperative mortality, morbidity and survival for patients underwent PD in middle-volume center.
Patients and Methods: Sixty patients with pancreatic tumors were enrolled in this study for different surgical procedure according to type of tumors.
Results: No early postoperative complications were observed in 60% of patients, whereas 40% of patients developed one or more complication, the median survival for this group was 12.3 months with standard deviation 3.8 months.
Pancreatic cancer is a deadly disease. In 2007, death due to pancreatic cancer is projected to approximate the incidence of the disease, with about 34,000 patients being diagnosed with pancreatic cancer in the United States [1].
The prognosis of patients with pancreatic cancer remains poor. Patients frequently present with distant metastases, which are often occult at the time of diagnosis and the 5-year survival rate is 5.6% for all patients diagnosed with pancreatic adenocarcinoma. Treatment for patients with potentially curable disease remains challenging, and the 5-year survival for patients with early stage disease is estimated at 15%, with median survival for patients with locally advanced disease remains limited at 6 to 11 months [2].
Advances in operative technique and patient care have limited perioperative morbidity and mortality for those fortunate enough to undergo resection. Nonetheless, surgical therapy (i.e. pancreatectomy) despite curative intent results in high rates of recurrence and disappointing median survivals of about 12 months [3].
The morbidity related to PD is still high, even in high-volume centers, although there has been improvement in the management of complications [4].
So in this study we evaluate perioperative mortality, morbidity and survival for patients underwent PD in middle-volume center.
2. Patient and Methods
This study was conducted at Surgical Oncology Unit, Oncology Centre, Mansoura University (OCMU) during the period between January 2005 & January 2012. Sixty patients with pancreatic tumors were enrolled in this study for different surgical procedure according to type of tumors.
Our inclusion criteria were operable pancreatic tumors candidates for surgery and exclusion criteria were metastatic cancer pancreas and celiac trunk encasement.
The following factors were analyzed: Patient demographics, intraoperative factors, as type of resection, blood loss, blood transfusion, and operative time, Tumor characteristics, including diameter, histologic grade, lymph node status and finally the primary outcome variable analyzed was survival. Follow-up was performed by office records, telephone contact; Survival was analyzed by the method of Kaplan and Meier test.
3. Results
Table 1 summarizes the patients characteristics and operative details.
ReferencesJ. M. Hernandez, S. M. Cowgill, S. Al-Saadi, A. Collins, S. B. Ross, J. Cooper, et al., “CA 19-9 Velocity Predicts Disease-Free Survival and Overall Survival after Pancreatectomy of Curative Intent,” Journal of Gastrointestinal Surgery, Vol. 13, No. 2, 2009, pp. 349-353. doi:10.1007/s11605-008-0696-3S. M. Russo, R. Ove and M. W. Saif, “Identification of Prognostic and Predictive Markers in Pancreatic Adenocarcinoma. Highlights from the 2011 ASCO Gastrointestinal Cancers Symposium,” Journal of the Pancreas, Vol. 12, No. 2, 2011, pp. 92-95. C. J. Wray, S. A. Ahmad, J. B. Matthews and A. M. Lowy, “Surgery for Pancreatic Cancer: Recent Controversies and Current Practice,” Gastroenterology, Vol. 128, No. 6, 2005, pp. 1626-1641.doi:10.1053/j.gastro.2005.03.035C. Bassi, M. Falconi, R. Salvia, G. Mascetta, E. Molinari and P. Pederzoli, “Management of Complications after Pancreaticoduodenectomy in a High Volume Centre: Results on 150 Consecutive Patients,” Digestive Surgery, Vol. 18, No. 6, 2001, pp. 453-457.doi:10.1159/000050193American Cancer Society, “Global Cancer Facts and Fig- ures [Database on the Internet],” American Cancer Society, Atlanta, 2002.A. M. Kriegel, A. S. Soliman, Q. Zhang, N. El-Ghawalby, F. Ezzat, A. Soultan, et al., “Serum Cadmium Levels in Pancreatic Cancer Patients from the East Nile Delta Region of Egypt,” Environmental Health Perspectives, Vol. 114, No. 1, 2006, pp. 113-119.S. Nagai, T. Fujii, Y. Kodera, M. Kanda, T. T. Sahin, A. Kanzaki, et al., “Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas,” Pancreas, Vol. 40, No. 1, 2011, pp. 3-9. doi:10.1097/MPA.0b013e3181f7147aC. J. Yeo, “Management of Complications Following Pancreaticoduodenectomy,” Surgical Clinics of North America, Vol. 75, No. 5, 1995, pp. 913-924. L. Capussotti, P. Massucco, D. Ribero, L. Vigano, A. Muratore and M. Calgaro, “Extended Lymphadenectomy and Vein Resection for Pancreatic Head Cancer: Out- comes and Implications for Therapy,” Archives of Surgery, Vol. 138, No. 12, 2003, pp. 1316-1322. doi:10.1001/archsurg.138.12.1316M. Niedergethmann, M. Farag Soliman and S. Post, “Postoperative Complications of Pancreatic Cancer Surgery,” Minerva Chirurgica, Vol. 59, No. 2, 2004, pp. 175-183.X. Dong, B. Zhang, M. X.Kang, Y. Chen, Q. Q. Guo and Y. L. Wu, “Analysis of Pancreatic Fistula According to the International Study Group on Pancreatic Fistula Classification Scheme for 294 Patients Who Underwent Pancreaticoduodenectomy in a Single Center,” Pancreas, Vol. 40, No. 2, 2011, pp. 222-228. doi:10.1097/MPA.0b013e3181f82f3cC. G. Yeo, “Whipple Procedure: 1935 to Present,” In: Douglas Evans PPaJA, Ed., Pancreatic Cancer 2002, pp. 125-137.J. D. Birkmeyer, A. L Warshaw, S. R Finlayson, M. R. Grove and A. N. Tosteson, “Relationship between Hospital Volume and Late Survival after Pancreaticoduodenectomy,” Surgery, Vol. 126, No. 2, 1999, pp. 178-183. doi:10.1016/S0039-6060(99)70152-2A. C. Berger, J. C. Watson, E. A. Ross and J. P. Hoffman, “The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma,” The American surgeon, Vol. 70, No. 3, 2004, pp. 235-240.M. Hellan, C. L. Sun, A. Artinyan, P. Mojica-Manosa, S. Bhatia, J. D. Ellenhorn, et al., “The Impact of Lymph Node Number on Survival in Patients with Lymph Node-Negative Pancreatic Cancer,” Pancreas, Vol. 37, No. 1, 2008, pp. 19-24. doi:10.1097/MPA.0b013e31816074c9T. M. Pawlik, A. L. Gleisner, J. L. Cameron, J. M. Winter, L. Assumpcao, K. D. Lillemoe, et al., “Prognostic Relevance of Lymph Node Ratio Following Pancreaticoduodenectomy for Pancreatic Cancer,” Surgery, Vol. 141, No. 5, 2007, pp. 610-618. doi:10.1016/j.surg.2006.12.013T. Zacharias, D. Jaeck, E. Oussoultzoglou, A. Neuville and P. Bachellier, “Impact of Lymph Node Involvement on Long-Term Survival after R0 Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas,” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, Vol. 11, No. 3, 2007, pp. 350-356. doi:10.1007/s11605-007-0113-3M. Adham, D. Jaeck, J. Le Borgne, E. Oussoultzouglou, M. P. Chenard-Neu, J. F. Mosnier, et al., “Long-Term Survival (5-20 Years) after Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Series of 30 Patients Collected from 3 Institutions,” Pancreas, Vol. 37, No. 4, 2008, pp. 352-357. doi:10.1097/MPA.0b013e31818166d2K. Tobita, H. Kijima, S. Dowaki, Y. Oida, H. Kashiwagi, M. Ishii, et al., “Thrombospondin-1 Expression as a Prognostic Predictor of Pancreatic Ductal Carcinoma,” Inter- national Journal of Oncology, Vol. 21, No. 6, 2002, pp. 1189-1195.G. Peros, G. A. Giannopoulos, S. Christodoulou, G. Konstantoudakis, K. Petropoulou and G. H. Sakorafas, “Good Results after Major Pancreatic Resections in a Middle-Volume Center,” Pancreas, Vol. 39, No. 3, 2010, pp. 411-414. doi:10.1097/MPA.0b013e3181bd94ceP. J. Lakhey, R. S. Bhandari, B. Ghimire and M. Khakurel, “Perioperative Outcomes of Pancreaticoduodenectomy: Nepalese Experience,” World Journal of Surgery, Vol. 34, No. 8, 2010, pp. 1916-1921. doi:10.1007/s00268-010-0589-yG. A. Gooiker, L. G. van der Geest, M. W. Wouters, M. Vonk, T. M. Karsten, R. A. Tollenaar, et al., “Quality Improvement of Pancreatic Surgery by Centralization in the Western Part of the Netherlands,” Annals of Surgical Oncology, Vol. 18, No. 7, 2011, pp. 1821-1829. doi:10.1245/s10434-010-1511-4R. Pezzilli, M. Falconi, A. Zerbi, R. Casadei, L. Valli, R. Varale, et al., “Clinical and Patient-Reported Outcomes after Pancreatoduodenectomy for Different Diseases: A Follow-Up Study,” Pancreas, Vol. 40, No. 6, 2011, pp. 938-945. doi:10.1097/MPA.0b013e318216f693